Levey, Andrew S.

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Heerspink, H. J. L., Greene, T., Tighiouart, H., Gansevoort, R. T., Coresh, J., Simon, A. L., Chan, T. M., Hou, F. F., Lewis, J. B., Locatelli, F., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 397

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

Coresh, J., Heerspink, H. J. L., Sang, Y., Matsushita, K., Arnlov, J., Astor, B. C., Black, C., Brunskill, N. J., Carrero, J.-J., Feldman, H. I., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 338

Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease study

Levey, A. S., Adler, S., Caggiula, A. W., England, B. K., Greene, T., Hunsicker, L. G., Kusek, J. W., Rogers, N. L., & Teschan, P. E. (1996) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 334

Testing for chronic kidney disease: a position statement from the National Kidney Foundation

Vassalotti, J. A., Stevens, L. A., & Levey, A. S. (2007) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 331

Resistance Training To Counteract the Catabolism of a Low-Protein Diet in Patients with Chronic Renal Insufficiency: A Randomized, Controlled Trial

Castaneda, C., Gordon, P. L., Uhlin, K. L., Levey, A. S., Kehayias, J. J., Dwyer, J. T., Fielding, R. A., Roubenoff, R., & Singh, M. F. (2001) · Annals of Internal Medicine

Muscle metabolism and nutritionDialysis and Renal Disease Management

Cited by 249

National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories

Miller, W. G., Kaufman, H. W., Levey, A. S., Straseski, J. A., Wilhelms, K. W., Yu, H. Y. (., Klutts, J. S., Hilborne, L. H., Horowitz, G. L., Lieske, J., et al. (2022) · Clinical Chemistry

Chronic Kidney Disease and DiabetesClinical Laboratory Practices and Quality Control

Cited by 222

Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study

Kopple, J. D., Levey, A. S., Greene, T., Chumlea, W. C., Gassman, J. J., Hollinger, D. L., Maroni, B. J., Merrill, D., Scherch, L. K., Schulman, G., et al. (1997) · Kidney International

Dialysis and Renal Disease ManagementChronic Kidney Disease and Diabetes

Cited by 219

A metabolome-wide association study of kidney function and disease in the general population

Sekula, P., Goek, O.-N., Quaye, L., Barrios, C., Levey, A. S., Römisch-Margl, W., Menni, C., Yet, I., Gieger, C., Inker, L. A., et al. (2016) · Journal of the American Society of Nephrology

Metabolomics and Mass Spectrometry StudiesChronic Kidney Disease and Diabetes

Cited by 203

Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals

Fan, L., Levey, A. S., Gudnason, V., Eiriksdottir, G., Andresdottir, M. B., Gudmundsdottir, H., Indridason, O. S., Palsson, R., Mitchell, G., & Inker, L. A. (2015) · Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 170

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease

Kent, D. M., Jafar, T. H., Hayward, R. A., Tighiouart, H., Landa, M., de Jong, P., de Zeeuw, D., Remuzzi, G., Kamper, A.-L., & Levey, A. S. (2007) · Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

Cited by 162

Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) study

Levey, A. S., Greene, T., Sarnak, M. J., Wang, X., Beck, G. J., Kusek, J. W., Collins, A. J., & Kopple, J. D. (2006) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 158

Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. Health Care Organizations

Stempniewicz, N., Vassalotti, J. A., Cuddeback, J. K., Ciemins, E., Storfer-Isser, A., Sang, Y., Matsushita, K., Ballew, S. H., Chang, A. R., Levey, A. S., et al. (2021) · Diabetes Care

Chronic Kidney Disease and DiabetesDiabetes Management and Research

Cited by 157

Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium

Shin, J.-I., Chang, A. R., Grams, M. E., Coresh, J., Ballew, S. H., Surapaneni, A., Matsushita, K., Bilo, H. J. G., Carrero, J. J., Chodick, G., et al. (2021) · Hypertension

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 155

In Search of a Better Equation — Performance and Equity in Estimates of Kidney Function

Diao, J. A., Inker, L. A., Levey, A. S., Tighiouart, H., Powe, N. R., & Manrai, A. K. (2021) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesRace, Genetics, and Society

Cited by 115

Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)

Lambers Heerspink, H. J., Weldegiorgis, M., Inker, L. A., Gansevoort, R., Parving, H.-H., Dwyer, J. P., Mondal, H., Coresh, J., Greene, T., Levey, A. S., et al. (2014) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 69